Page 2 - Expanded Use Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Matinas BioPharma Holdings Inc (MTNB) Reports Q3 2023 Financial Results and Business Progress

Key Developments and Financial Highlights for Investors

Jeromed jabbourMatinas biopharmaCompassionate expanded use access programMatinas biopharma holdings incExpanded use access programMatinas biopharmaMarketable securitiesCash equivalentsClinical programsIopharmaceutical companyNet loss

U of M research team successfully tests new antifungal therapy for fungal meningitis

A team of University of Minnesota Medical School researchers successfully tested a new antifungal therapy to treat fungal meningitis. The trial results were published today in the peer-reviewed journal Clinical Infectious Diseases.

Matinas biopharmaDavid boulwareMahsa abassiTheresa matkovitsSchool of public healthM medical schoolM health fairviewUniversity of minnesota medical schoolCompassionate expanded use access programInfectious diseases institute of makerere universityMinnesota medical schoolClinical infectiousMedical schoolPublic healthInfectious diseases instituteMakerere university

Matinas BioPharma Announces Publication of Results from the Phase 2 EnACT Clinical Trial of MAT2203 in the IDSA Journal Clinical Infectious Diseases

BEDMINSTER, N.J., Aug. 22, 2023 Matinas BioPharma , a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal platform delivery.

United statesMatinas biopharmaTheresa matkovitsDavid boulwareJody cainNational institutes of healthInfectious diseases society of americaNational institute of neurological disordersNational resilience incUniversity of minnesotaUniversity of minnesota medical schoolCompassionate expanded use access programMinnesota medical schoolMajor articleClinical infectious diseasesInfectious diseases society

New antifungal therapy for fungal meningitis

New antifungal therapy for fungal meningitis
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Mahsa abassiMatinas biopharmaTheresa matkovitsDavid boulwareCompassionate expanded use access programInfectious diseases institute of makerere universityUniversity of minnesota medical schoolM health fairviewSchool of public healthM medical schoolMinnesota medical schoolMedical schoolPublic healthInfectious diseases instituteMakerere universityChief development officer

Research team successfully tests new antifungal therapy for fungal meningitis

Research team successfully tests new antifungal therapy for fungal meningitis
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Mahsa abassiDavid boulwareTheresa matkovitsDavidr boulwareMatinas biopharmaM health fairviewM medical schoolUniversity of minnesota medical schoolSchool of public healthCompassionate expanded use access programInfectious diseases institute of makerere universityClinical infectious diseasesMinnesota medical schoolClinical infectiousMedical schoolPublic health